This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Eli Lilly & Company

Drug Names(s): Olanzapine and Fluoxetine HCl

Description: Symbyax is indicated for the treatment of depressive episodes associated with bipolar disorder. Symbyax (Olanzapine and Fluoxetine HCl capsules) combines 2 psychotropic agents, Olanzapine (the active ingredient in Zyprexa and Zyprexa Zydis) and Fluoxetine hydrochloride (the active ingredient in Prozac, Prozac Weekly, and Sarafem). Olanzapine belongs to the thienobenzodiazepine class. Fluoxetine hydrochloride is a selective serotonin reuptake inhibitor (SSRI).

Symbyax News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug